FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company is focused on fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, the Company's most advanced product candidate, is an oral small molecule inhibitor of HIF prolyl hydroxylase activity in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD), and is entering Phase III development for anemia in lower risk myelodysplastic syndromes (MDS). The Company has developed Pamrevlumab. Pamrevlumab is a proprietary therapeutic antibody to inhibit the activity of connective tissue growth factor (CTGF), a common factor in chronic fibrotic and proliferative disorders characterized by persistent and excessive scarring that can lead to organ dysfunction and failure.

Hospital

FibroGen

FibroGen's headquarters in San Francisco, CA, United States

This department manages employee relations, recruitment, compensation, benefits, and overall workforce administration.

Human Resources

This department conducts research and experimentation to advance scientific knowledge and develop innovative solutions.

Scientific Research

The Leadership Team at FibroGen is responsible for strategic decision-making and oversight of the company's development and commercialization efforts. This multi-disciplinary group collaborates to guide the company's innovative pipeline of therapeutics in fibrosis, anemia, and cancer, ensuring alignment between clinical development, regulatory affairs, intellectual property, and operational management. Their leadership fosters a cohesive environment that drives the advancement of FibroGen's mission to deliver first-in-class therapies to patients.

Leadership Team

This department is responsible for overseeing financial planning, analysis, and reporting to support organizational decision-making.

Financial Planning and Analysis

The Clinical Development Team at FibroGen is responsible for designing, implementing, and overseeing clinical trials to evaluate the safety and efficacy of the company's innovative therapeutics. This team collaborates closely with various stakeholders to ensure regulatory compliance, manage clinical data, and assess drug safety through pharmacovigilance. Their work is critical in advancing FibroGen’s pipeline of treatments for anemia, fibrotic diseases, and cancer, ultimately paving the way for new therapeutic options for patients.

Clinical Development Team

This department provides strategic direction and oversight for the organization's operations and governance.

People (4)

Jobs (0)

Other teams

Scientific Research

Leadership Team

Financial Planning and Analysis

Clinical Development Team

Executive Leadership